Latest filing published 16 Sept 2025 for Tarsus Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Scott W. Morrison (board member) discloses dealings in 3 companies, chiefly Tarsus Pharmaceuticals, Inc., Zai Lab Ltd and Global Blood Therapeutics, Inc. Over a trading history stretching from 17 June 2021 to 15 September 2025, the count stands at 15 filings.
On the market, this insider has only sold: 2 sales, €760k in total. Besides market trades, the filings include 4 share grants and 7 option exercises. Since January 2025: no purchases and 1 sale on the market.
The latest filing, published on 16 September 2025, reports an option exercise in Tarsus Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations